Suchitra Sundaram
@SSundaramMDLymphoma/CLL physician at Mount Sinai Icahn School of Medicine, NYC. Former lymphoma doc @RoswellPark.👩🎓: @ClevelandClinic @CWRU
Similar User
@CraigMoskMD
@PallawiTorkaMD
@DrJFriedberg
@UjjaniC
@LiaPalomba
@sridevirajeeve
@chanyooncheah
@priyankapophali
@DrCarlaCasulo
@CwynKate
@DrLizBrem
@drjoannarhodes1
@YucaiWangMD
@PaolaGhione_MD
@Chauhan_AF
Excellent Junior Faculty career development session on now at #ASH23 Dr. Oyebimpe Adesina and Dr. Cassandra Josephson sharing their journey on securing and staying funded as junior faculty. Great tips and many take-aways! “Persistence is key” #lymsm
Useful data by Dr.Lacoboni: Prior Benda exposure did NOT impact CRS,toxicities, survival w/BsAb therapy in DLBCL&FL. More pts w/shorter washout b4 BsAb needed to explore the impact of more recent Benda exposure on outcomes,(small# DLBCL pts with Benda use within 6m had lower PFS)
Another ctDNA study suggesting greater predictive value over PET. @RoschewskiMD EOT response post 1L in DLBCL, Landmark comparison of EOT PET vs ctDNA. Undetectable ctDNA by PhasED-sea at EOT predicts a very low likelihood of progression potentially sparing more biopsies/imaging
Sworder et al MRD detection in DLBCL using PhasED-Seq Ct-DNA-MRD predicts outcomes when discordant with PET: Outcomes for CT-DNA+, PET - worse than CTDNA-PET+. Need to overcomes barriers for its use to treat & consolidate in RW practice #ASH23
Simplify geriatric assessments! Easy to administer “Timed up and go” as an objective measure of frailty and predictor of severe therapy related toxicity in DLBCL. Outstanding work by @PallawiTorkaMD #lymsm #ASH23
Shout out to my fellow LSRMP colleague @ArushiKhurana4 analysis of BCL6-R outcomes in the LEO consortium BCL-6 DHL outcomes are more comparable to DLBCL NOS than BCL 2 R #ASH23
I’m tired of my job! Work is not fun anymore! ‘Should I stay or should I go?’ Join @UDurani @MayoClinic and me @RoswellPark as we chat about 👉 pros/cons 👉strategies for success Session: Junior Faculty Career Development #ASH22 Time: 4.30-5.45pm Monday (we start at 5 pm)
Ofatumumab- HyperCVAD in MCL This paper has been in making for many years and am proud to announce that its finally out in #CancerJournal. O-HyperCVAD induced 96% MRD negativity by flow post induction but PFS and OS only 46 mo and 56 mo still acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…
Safety and Efficacy of Tisagenlecleucel in Primary CNS Lymphoma: A phase I/II clinical trial ashpublications.org/blood/article/… Congratulations @MJFzeta and team who took impressively good care of our patients.
Calling all folks who treat patients with lymphoma! Please fill out our survey about how you use polatuzumab vedotin in your clinical practice, as part of a new IRB-approved study: redcap.link/cekd9rqy #lymsm #onctwitter #hemetwitter
We look forward to hearing about #AML from Eunice Wang, MD. Jan. 13. roswellpark.org/eunice-wang @RoswellPark @IcahnMountSinai
After arriving in Buffalo, NY in 1883, Dr. Roswell Park began to focus more intently on the mystery of cancer. Read the story of the world’s first cancer research center (@RoswellPark) cancerhistoryproject.com/institutions/i…
Dr Kanti Rai once said “… no one is an expert in CLL. I have been studying this disease for decades, and still too many of my patients die. If I were truly an expert, the disease would have been cured by now.” thank you for reminding us @DavidSteensma ascopubs.org/doi/full/10.12…
#TCL updates #ASH21 #lymsm Abs 620 @LysaLymphoma : BV+benda in R/R TCL Retrospective, n=82 Benda mono: ORR 50% PFS 3.6 mo BV mono in ALCL: ORR 86% CR 57% PFS 13.3 mo CD30+ 63%, 50% refractory B2: ORR 70%, CR 51% PFS 8.3 mo OS 26.3 mo Utility in our practice @PaolaGhione_MD?
Mind officially blown🤯🤯 This opens so many lines of investigation! Could CHIP be an evolutionary mechanism to prevent AD like #SCD for malaria? since AD is more common in Caucasians, interested to know CHIP incidence in other populations! @DavidSteensma @SwapnaThota
So that was impressive @jaiswalmdphd @TrowbridgeLab : Dr Hind Bouzid presented several lines of evidence that CHIP reduces Alzheimer risk (multiple cohorts, clonal cells in brain indistinguishable from microglia). Hypothesis #CHIP cells supplement loss of microglia during aging.
RCHOP may fare as good as higher intensity regimens in #HGBCL-NOS, excl. Burkitt and DHL Key data in an understudied population. Great analysis and alluvial plot illustration by @AdamZayac and grateful for the collaboration !
#lymphoma updates in #ASH21 Detailed descriptive data on high grade B cell lymphoma (HGBCL) with beautiful pictorial depiction. Glad to be part of this multicenter effort with @SSundaramMD @RoswellPark
#DLBCL landscape in a GIF (sic) #Bispecifics to appear here next? #ASH21
This is by no means comprehensive. But shows how we are moving away from “one size fits all” in DLBCL (does not include HGBCL-DH/TH)
"Add on" U2 in pts w/detectable MRD while on ibrutinib➡️MRD-guided discontinuation. 77% achieving uMRD, 1st as early as ~7m, unchanged AE profile,v high PFS. Another potential time limited therapy in #CLL; saves venetoclax for later. Outstanding presentation by @LRoekerMD #ASH21
Non covalent BTKis ruling CLL again #pirtobrutinib #nemtabrutinib!Continued impressive waterfall plot with Pirtobrutinib incl. post BTKi-BCL2, del 17p,independent of C481Sm w/ Rx discontinuation rate <1% Cant get better than this!Excellent talks by @anthonymato& Dr.JenniferWoyach
United States Trends
- 1. Kendrick 749 B posts
- 2. #AskShadow 27,6 B posts
- 3. MSNBC 247 B posts
- 4. Scott Bessent 14,2 B posts
- 5. Khalid 16,1 B posts
- 6. $LEAFS N/A
- 7. Jonathan India 2.269 posts
- 8. The Warm Up 17,1 B posts
- 9. Singer 63,2 B posts
- 10. Reds 13,2 B posts
- 11. Royals 11,2 B posts
- 12. Drake 96,2 B posts
- 13. LinkedIn 44,8 B posts
- 14. Luther 55,3 B posts
- 15. Lori Chavez 1.586 posts
- 16. Brandon Allen 2.504 posts
- 17. Wayne 64,7 B posts
- 18. Joey Wiemer 1.464 posts
- 19. Kdot 11,4 B posts
- 20. Friday Night Lights 1.293 posts
Who to follow
-
Craig Moskowitz, MD
@CraigMoskMD -
Pallawi Torka
@PallawiTorkaMD -
Jonathan Friedberg
@DrJFriedberg -
Chaitra Ujjani, MD
@UjjaniC -
Lia Palomba
@LiaPalomba -
Sridevi Rajeeve, MD
@sridevirajeeve -
Chan Cheah
@chanyooncheah -
Priyanka Pophali, MD
@priyankapophali -
Carla Casulo, MD
@DrCarlaCasulo -
Kate Cwynarski
@CwynKate -
Liz Brem
@DrLizBrem -
Joanna M. Rhodes, MD, MSCE
@drjoannarhodes1 -
Yucai Wang, MD, PhD
@YucaiWangMD -
Paola Ghione MD, MSEpi
@PaolaGhione_MD -
Ayushi Chauhan
@Chauhan_AF
Something went wrong.
Something went wrong.